510(k) · Cleared
ClearedReference Check, Catalog Number-RCN-10
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Precision Biologic · GIZ Plasma, Control, Normal
Cleared on Dec 10, 2001 as substantially equivalent to K001256 (Dade Behring, Inc., 2000) after a 32-day review. Its family tree reaches back 1 generation to 2000. 1 later device descends from it.
- Decided
- Dec 10, 2001
- Review
- 32 days
- Class
- Class II
- Product code
- GIZ
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K001256 (2000). 1 later device descends from it, 1 citing it directly.
- Root · 1 generation backK001256 Control Plasma NDade Behring, Inc. · 2000
- This deviceK013708 Reference Check, Catalog Number-RCN-10Precision Biologic · 2001
- Descendant · cites it directly · 0 of its ownK091284 Visucal-F Frozen Calibrator Plasma and Visucon-F Frozen Normal and…Affinity Biologicals, Inc. · 2009
Most influential descendants
Showing 1 of 1 · See all- K091284Visucal-F Frozen Calibrator Plasma and Visucon-F Frozen Normal and Abnormal Control PlasmaAffinity Biologicals, Inc. · 2009 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K001256 | Control Plasma N | Dade Behring, Inc. | 2000 | — |
| 0 (this device) | K013708 | Reference Check, Catalog Number-RCN-10 | Precision Biologic | 2001 | — |
| +1 | K091284 | Visucal-F Frozen Calibrator Plasma and Visucon-F Frozen Normal and Abnormal… | Affinity Biologicals, Inc. | 2009 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2009 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GIZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K001256 | Control Plasma NSummary page 1…gic.com November 7, 2001 Reference Check Common Name: Normal Control Plasma Classification Name: Plasma, Control, Normal Regutatory Class I, 81 GIZ Control Plasma N (K001256) Dade Behring Inc. Newark, Delaware 19714 USA Reference Check is citrated human plasma collected from 20 or more carefully scre… | 2000 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K091284 | Visucal-F Frozen Calibrator Plasma and Visucon-F Frozen Normal and Abnormal Control Plasma | 2009 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All GIZ devicesGIZ Plasma, Control, Normal: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · GIZ
1in 2007
2026 to Oct 25, outlined.
Median 510(k) review, days · GIZ
Too few GIZ 510(k)s in any year since 2007 to give a median.
Recalls per year · GIZ
1in 2019
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GIZ
No MAUDE report names GIZ since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 1 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
Reference Check is recommended for use in controlling the accuracy of quantitative hemostasis assays in the normal range. Reference Check is an assayed control for the following parameters in the normal range:
Fibrinogen
Factor il
Factor V
Factor VIi
Factor VIII:C
VvWF: antigen
VWF: Ristocetin Cofactor
Factor IX
Factor X
Factor XI
Factor Xl
Factor Xili
Prekallikrein
Protein C: antigen
Protein C: activity
Protein S: activity
Protein S: total
Protein S: free
Antithrombin: activity
Antithrombin: antigen
Alpha-2-antiplasmin
Plasminogen
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K013708 · printed Nov 6, 2026
Cite this page
510(k) Report. “K013708: Reference Check, Catalog Number-RCN-10.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K013708
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026